CrowdStrike stock steadies premarket after Anthropic’s Claude Code Security rattles cyber shares

CrowdStrike stock steadies premarket after Anthropic’s Claude Code Security rattles cyber shares

New York, Feb 23, 2026, 04:55 EST — Premarket

  • CrowdStrike (CRWD) edged 0.6% higher ahead of the bell, rebounding somewhat after Friday’s nearly 8% tumble.
  • Investors are debating if the emergence of new AI-powered security tools will squeeze certain segments of the cybersecurity software space.
  • CrowdStrike’s results are due March 3; investors will be zeroing in on both guidance and commentary around AI.

CrowdStrike bounced 0.6% to $391 before the bell on Monday, making up just a fraction of Friday’s 7.95% drop. Shares wrapped up last week at $388.60.

This shift is notable—fresh concerns over “AI disruption” have already been driving investors away from pricey software stocks, with cybersecurity now getting caught up too. It’s a critical moment for CrowdStrike, as the chatter lands just before its earnings; a tweak in commentary on demand or the competitive landscape could quickly ripple through shares.

The introduction of a security update to Anthropic’s Claude model set off a wave of selling in cybersecurity stocks on Friday, according to BankInfoSecurity. Cloudflare, Okta, and SailPoint each tumbled between 8% and 9%. The iShares Expanded Tech-Software Sector ETF has now lost about 23% for the year, the report noted.

Anthropic has rolled out Claude Code Security, a tool designed to scan codebases for vulnerabilities and recommend specific fixes—though a human still has to approve any changes. According to the company, “a significant share of the world’s code” could soon be combed over by AI. During internal tests, Anthropic says it surfaced over 500 new high-severity vulnerabilities in major open-source projects. Anthropic

Some investors aren’t worried about CrowdStrike’s platform getting cloned out of the blue. The real concern, they say, is that AI could slash the costs of switching providers. “The risk for big brands is not that someone will recreate Splunk or CrowdStrike overnight,” Shay Michel, managing partner at Merlin Ventures, told Calcalist. AI agents, he said, might drive migration costs “to almost zero.” Meanwhile, Kobi Samboursky, managing partner at Glilot Capital, pointed out that while smaller companies might settle for what Claude offers, large firms won’t be able to skip deep cyber know-how. ctech

The question for the market: just what is getting disrupted here? CrowdStrike’s business spans endpoint and cloud security, along with identity and data protection. Now traders are left parsing whether an AI code scanner is a direct threat to those core offerings—or if it’s more likely to shake up specialized code-testing and supply-chain products instead.

CrowdStrike’s Falcon platform, delivered via subscription, collects data from endpoints, cloud workloads, identities, and outside sources, Reuters notes in its company summary.

CrowdStrike will release its fourth-quarter and full-year fiscal 2026 numbers after the bell on March 3, with a conference call set for 5 p.m. Eastern. The market’s focus: updated guidance and specifics on how CrowdStrike aims to cash in on AI, as competition intensifies in security workflows.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY

Pfizer

NYSE: PFE 93 / 100
#2 TACTICAL BUY

AMD

NASDAQ: AMD 91 / 100
#3 STRONG BUY

AerCap

NYSE: AER 90 / 100
#4 BUY ONLY ON PULLBACK

Booking Holdings

NASDAQ: BKNG 88 / 100
#5 BUY ON WEAKNESS

Visa

NYSE: V 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Vanda Pharmaceuticals stock jumps premarket after FDA clears Bysanti — what to watch at the open
Previous Story

Vanda Pharmaceuticals stock jumps premarket after FDA clears Bysanti — what to watch at the open

Rackspace (RXT) stock back in play as Palantir AI deal meets earnings week
Next Story

Rackspace (RXT) stock back in play as Palantir AI deal meets earnings week